Skip to main content

Table 5 Outcome of HNSCC Patients According to The Combined Status of Her3 and Her3 Membranous Staining

From: Membranous expression of Her3 is associated with a decreased survival in head and neck squamous cell carcinoma

Tumor markers Total Median OS (months) Hazard Ratio (95% CI) P value
Her2-/Her3- 262 36.0 1.13 (0.87-1.47) 0.342
Her2+/Her3- 91 51.0 0.70 (0.51-0.95) 0.020
Her2-/Her3+ 21 25.0 1.53 (0.95-2.47) 0.074
Her2+/Her3+ 13 22.0 1.48 (0.78-2.79) 0.216